¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular immunity deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • cast syndrome
    ¼®°íºØ´ëÁõÈıº
  • cat¡¯s cry syndrome
    °í¾çÀÌ¿ïÀ½ÁõÈıº
  • cat-eye syndrome
    °í¾çÀÌ´«ÁõÈıº
  • cauda equina syndrome
    ¸»ÃÑÁõÈıº, ¸¶¹ÌÁõÈıº
  • central cord syndrome
    Áß½Éô¼öÁõÈıº
  • central pain syndrome
    ÁßÃßÅëÁõÁõÈıº
  • Chinese restaurant syndrome
    Áß±¹À½½ÄÁõÈıº
  • camptomelic syndrome
    ±¼ÁöÁõÈıº
  • chromosomal breakage syndrome
    ¿°»öüÆÄ¼ÕÁõÈıº
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • dry eye syndrome
    °Ç¼º¾ÈÁõÈıº, ¾È±¸°ÇÁ¶Áõ
  • dumping syndrome
    ºü¸¥ºñ¿òÁõÈıº, ´ýÇÎÁõÈıº
  • defibrination syndrome
    Å»¼¶À¯¼ÒÁõÈıº, Å»ÇǺ기ÁõÈıº
  • deficit syndrome
    °áÇÌÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate malabsorption syndrome
    ´çÁúÈí¼öºÒ·®ÁõÈıº
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº
  • carpal tunnel syndrome
    ¼Õ¸ñ±¼ÁõÈıº
  • cast syndrome
    ¼®°íºØ´ëÁõÈıº
  • cat¡¯s cry syndrome
    °í¾çÀÌ¿ïÀ½ÁõÈıº
  • cauda equina syndrome
    ¸»ÃÑÁõÈıº
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
  • central artery syndrome
    Á߽ɵ¿¸ÆÁõÈıº
  • central cord syndrome
    Áß½Éô¼öÁõÈıº
  • central pain syndrome
    ÁßÃßÅëÁõÁõÈıº
  • cerebrovascular syndrome
    ³úÇ÷°üÁõÈıº
  • Chinese restaurant syndrome
    Áß±¹À½½ÄÁõÈıº
  • chromosomal breakage syndrome
    ¿°»öüÆÄ¼ÕÁõÈıº, ¿°»öüºÒ¾ÈÁ¤ÁõÈıº
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • B-K mole syndrome
    B-K¸ð¹Ý ÁõÈıº
  • Bantis syndrome
    ¹ÝƼÁõÈıº.
  • Bare lymphocyte syndrome
    ¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº.
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº
  • Benedikts syndrome
    º£³×µñÆ®ÁõÈıº
  • Blackfan-Diamond syndrome
    ºí·¢ÆÇ-´ÙÀ̾ƸóµåÁõÈıº
  • Bloom syndrome
    ºí·ç¿òÁõÈıº(¡­ñøý¦ÏØ).
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
  • CREST syndrome
    Å©·¹½ºÆ® ÁõÈıº
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Cestans syndrome
    ¼¼½ºÅºÁõÈıº.
  • Chandlers syndrome
    îµé·¯ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµåÁõÈıº.
  • Charcots syndrome
    »þ¸£ÄÚÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • innate immunity
    ÀÚ¿¬¸é¿ª(í»æÔØóæ¹), ¼±Ãµ¸é¿ª(à»ô¸Øóæ¹).
  • intrauterine immunity
    Àڱó»¸é¿ª(¡­Øóæ¹).
  • local immunity
    ±¹¼Ò¸é¿ª(ÏÑá¶Øóæ¹).
  • maternal immunity
    ¸ð¼º¸é¿ª(¡­Øóæ¹).
  • maternal immunity
    ¸ð¼º¸é¿ª(ÊÙËÎËç).
  • maturation immunity
    ¼º¼÷¸é¿ª(à÷âÙØóæ¹).
  • natural immunity
    ÀÚ¿¬¸é¿ª(~Øóæ¹).
  • nonspecific immunity
    ºñƯÀ̼º ¸é¿ª(~Øóæ¹).
  • opsonic immunity
    ¿É¼Ò´Ñ¸é¿ª(¡­Øóæ¹).
  • partial immunity
    ºÎºÐ¸é¿ª(Ý»ÝÂØóæ¹).
  • passive immunity
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹).
  • permanent immunity
    ¿µ±¸¸é¿ª(¡­Øóæ¹).
  • peroral immunity
    °æ±¸¸é¿ª(¡­Øóæ¹).
  • phagocytic immunity
    ½Ä¼¼Æ÷¼º¸é¿ª (¡­Øóæ¹).
  • protective immunity
    ¹æ¾î¸é¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
RS radioscaphoid; random sample; rating schedule; Raynaud syndrome; recipient's serum; rectal sinus; re...
AIDS Acquired Immuno(Immune)-Deficiency Syndrome; ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
MEDAC Syndrome Multiple-Endocrine Deficiency Autoimmune-Candidiasis
AIDS acquired immune deficiency syndrome
AIDS-KS acquired immune deficiency syndrome with Kaposi's sarcoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
alpha1ATD Alpha-1-antitrypsin deficiency
AATD Alpha1-antitrypsin deficiency
BLAD Bovine Leukocyte Adhesion Deficiency
CPHD Combined pituitary hormone deficiency
CVID Common Variable Immuno-Deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anterior cornual syndrome
    Àü°¢ ÁõÈıº
    ô¼ö Àü°¢ÀÇ »óÇØ¸¦ ³ªÅ¸³»°í, ¿îµ¿ ¸¶ºñ¿Í ±Ù À§ÃàÀÌ Æ¯Â¡ÀÌ´Ù.
  • anterior spinal artery syndrome
    Àüô¼ö µ¿¸Æ ÁõÈıº
  • anterior spinal syndrome
    Àü»è ÁõÈıº
  • anticholinergic syndrome
    Ç×Äݸ°¼º ÁõÈıº
    °æÁõ °íÇ÷¾Ð°ú ºó¸ÆÀÌ ÀϹÝÀûÀ̸ç, ü¿ÂÀº ÈçÈ÷ »ó½ÂµÈ´Ù. µ¿°øÀº ±¤¹üÀ§ÇÏ°Ô È®ÀåµÇ¾î ÀÖ´Ù. ÇǺδ ¹ßÀûµÇ¾î ÀÖ°í ¶ß°Ì°í °ÇÁ¶ÇÏ´Ù. Àå ¿îµ¿Àº °¨¼ÒÇÏ°í ¿ä Á¤Ã¼
  • anxiety syndrome
    °í¹Î ÁõÈıº, ºÒ¾È ÁõÈıº
    Á¤½ÅÀû °í¹Î¿¡ ¼ö¹ÝÇÏ´Â ÁõÈıºÀ¸·Î, ½É°èÇ×Áø, È£Èí°ï¶õ, ¹ßÇÑ, ¾È»ö â¹é, °øÆ÷ µîÀ» ³ªÅ¸³½´Ù.
  • aortitis syndrome
    ´ëµ¿¸Æ¿° ÁõÈıº
  • apallic syndrome
    ¹«½É ÁõÈıº
  • apathetic-akinetic syndrome
    ¹«°¨µ¿-¹«µ¿ÀÛ ÁõÈıº
  • Apert syndrome
    ¿¡ÆÛÆ® ÁõÈıº, ¾ÆÆä¸£Æ® ÁõÈıº
    ÀÓ»óÀûÀ¸·Î µÎ°³°ñ ºÀÇÕÀÇ Á¶±â Æó¼â·Î ÀÎÇÑ µÎ°³ ±âÇü, ¾È¸é Á߾ӺΠÇü¼º ºÎÀü, ¾çÃø¼º ÇÕÁöÁõÀ¸·Î Á¤ÀǵȴÙ. µå¹® Àå¾Ö·Î¼­ ¶§·Î »ó¿°»öü ¿ì¼º À¯ÀüÀÌ °üÂûµÇ±âµµ Çϳª º¸ÅëÀº »ê¹ßÀûÀÎ µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ¹ß»ýµÈ´Ù.
  • arthritis-dermatitis syndrome
    °üÀý¿°-ÇǺο° ÁõÈıº
  • Ashermans syndrome
    ¾Æ¼Å¸¸ ÁõÈıº
    Àڱó» ¿ìÂø¿¡ ÀÇÇÏ¿© Áö¼Ó¼º ¹«¿ù°æ°ú ÀÌÂ÷¼º ºÒÀÓÀÌ ³ªÅ¸³ª´Â °Í. º¸Åë Àڱó» ¼ÒÆÄÀÇ °á°ú·Î ÀϾ´Ù.
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • atypical schizophrenic syndrome
    ºñÁ¤Çü Á¤½ÅºÐ¿­¼º ÁõÈıº
  • autoerythrocyte sensitization syndrome
    ÀÚ°¡ ÀûÇ÷±¸ °¨ÀÛ ÁõÈıº
    ÁÖ·Î ÀþÀº ¿©ÀÚ¿¡°Ô º¼ ¼ö ÀÖ´Â ÀÚ¹Ý ¹ÝÀÀÀÇ ÀÏÁ¾À¸·Î ¿Ü»ó ¾øÀÌ ¶Ç´Â ºÒ¿ÏÀü ¿Ü»ó ÈÄ ½Åü¿¡ ÀÚ¿¬ÀûÀ¸·Î µ¿ÅëÀ» µ¿¹ÝÇÏ°í ¹Ýº¹ÇÏ¿© ´Üµ¶ ¶Ç´Â ´Ù¹ß¼º ¹Ý»ó ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ¸¹Àº Áõ·Ê¿¡¼­ ÀûÇ÷±¸ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ °ú¹Î¼ºÀÌ ¿øÀÎÀ¸·Î »ý°¢µÇ³ª, ¹éÇ÷±¸°¡ ¿øÀÎÀ¸·Î »ý°¢µÇ´Â ¿¹µµ ÀÖ´Ù. Á¤¼­Àû Àå¾Ö°¡ ¹ßº´ °á½Ç ÀÎÀÚ·Î º¸ÀδÙ.
  • Axenfeld syndrome
    ¾Ç¼¾ÆçÆ® ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
pyruvate carboxylase deficiency An autosomal recessive pyruvate metabolism disorder resulting from absent or deficient expression of pyruvate carboxylase activity. Decreased production of oxaloacetate leads to decreased gluconeogenesis, thereby causing fasting hypoglycaemia, lactic acid acidosis, and decreased synthesis of amino acid neurotransmitters. Clinical presentations include acidosis, ataxia, mental retardation; sometimes co-occurs with leigh disease.
(12 Dec 1998)
pyruvate dehydrogenase complex deficiency An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia.
(12 Dec 1998)
pyruvate kinase deficiency A disorder in which there is a deficiency of pyruvate kinase in red blood cells; characterised by haemolytic anaemia varying in degree from one patient to another; autosomal recessive inheritance.
(05 Mar 2000)
hypoxanthine guanine phosphoribosyltransferase deficiency A sex-linked inherited metabolic disorder; complete deficiency results in Lesch-Nyhan syndrome; incomplete deficiency is associated with acute gouty arthritis and renal stones.
(05 Mar 2000)
steroid sulfatase deficiency A form of ichthyosis, due to 3-beta-hydroxysteroidsulfate sulfatase deficiency, that appears at birth or in early infancy and affects males; characterised by scaling predominantly on the neck and trunk but not on the palms and soles; histologically, there is hyperkeratosis, a granular layer in the epidermis, and normal epidermal cell turnover.
Synonym: steroid sulfatase deficiency.
(05 Mar 2000)
niacin deficiency <biochemistry> A niacin deficiency disease (pellagra) caused by improper diet and characterised by skin lesions, gastrointestinal disturbances and nervousness. Depression, dermatitis, dementia and diarrhoea are common symptoms.
(27 Sep 1997)
debrancher deficiency Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme).
Synonym: brancher deficiency glycogenosis, debrancher deficiency.
(05 Mar 2000)
deficiency A lack or defect.
(18 Nov 1997)
deficiency, alpha-1 antitrypsin An inherited disease with little or no production of an important protein, alpha-1 antitrypsin. The lack of this protein leads to damage of various organs, mainly the lung and liver. The disease may become apparent at a very early age or in adulthood, as shortness of breath or liver-related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant
(12 Dec 1998)
deficiency anaemia Any anaemia resulting from a dietary deficiency of materials essential to red blood cell formation, e.g., iron, vitamins (especially folic acid), protein.
Synonym: deficiency anaemia.
(05 Mar 2000)
deficiency, calcium A low blood calcium (hypocalcaemia). Hypocalcaemia makes the nervous system highly irritable with tetany (spasms of the hands and feet, muscle cramps, abdominal cramps, overly active reflexes, etc.). Chronic calcium deficiency contributes to poor mineralization of bones, soft bones (osteomalacia) and osteoporosis; and, in children, rickets and impaired growth. Food sources of calcium include dairy foods, some leafy green vegetables such as broccoli and collards, canned salmon, clams, oysters, calcium-fortified foods, and tofu. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
deficiency dermatitis and diarrhoea, zinc A genetic disease called acrodermatitis enteropathica is characterised by the simultaneous occurrence of skin inflammation (dermatitis) and diarrhoea. The skin on the cheeks, elbows and knees and tissue about the mouth and anus are inflammed. There is also balding of the scalp, eyebrows and lashes, delayed wound healing and recurrent bacterial and fungal infections due to immune deficiency. The key laboratory finding is an abnormally low blood zinc level reflecting impaired zinc uptake. Oral treatment with zinc is curative.
(12 Dec 1998)
deficiency disease Any disease resulting from undernutrition or an inadequacy of calories, proteins, essential amino acids, fatty acids, vitamins, or trace minerals.
(05 Mar 2000)
deficiency diseases A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories.
(12 Dec 1998)
deficiency, glucocerebrosidase Causes Gaucher's disease (type 1), a progressive genetic disease, due to an enzyme defect. The enzyme, glucocerebrosidase, is needed to break down the chemical glucocerebroside. The enzyme defect in persons with Gaucher's disease (GD) leads to the accumulation of glucocerebroside in the spleen, liver, and lymph nodes. The most common early sign is enlargement of the spleen (located in the upper left abdomen). Other signs include low red blood cell counts (anaemia), a decrease in blood clotting cells (platelets), increased pigmentation of the skin, and a yellow fatty spot on the white of the eye (a pinguecula). Severe bone involvement can lead to pain and collapse of the bone of the hips, shoulders, and spine. The GD gene is on chromosome 1. The disease is a recessive trait. Both parents carry a GD gene and transmit it for their child with the disease. The parents' risk of a child with the disease is 1 in 4 with each pregnancy. This type of Gaucher's disease (noncerebral juvenile Gaucher's disease) is most common in Ashkenazi Jews (of European origin) and is the most common genetic disease among Jews in the United States.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á